Alfred H J Kim
Overview
Explore the profile of Alfred H J Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
2086
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chandler A, Hamid M, Jiao Z, Hulcher K, Sharma I, Odom P, et al.
ACR Open Rheumatol
. 2025 Mar;
7(3):e70018.
PMID: 40033675
Objective: The purpose of this study was to pilot test a patient-reported social risk factor (SRF) screening tool among rheumatology outpatients and to examine the distribution of SRFs in this...
2.
Haidar G, Thomas S, Loubet P, Baker R, Benfield T, Boonyaratanakornkit J, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 40015292
Background: Sipavibart is an anti-spike monoclonal antibody that neutralises SARS-CoV-2 with exceptions, including Phe456Leu-containing variants (eg, KP.2* and KP.3*). This trial assessed sipavibart efficacy and safety for prevention of symptomatic...
3.
Calabrese L, Putman M, Sparks J, Wallace Z, Kim A, Winthrop K, et al.
Arthritis Rheumatol
. 2025 Jan;
PMID: 39817308
No abstract available.
4.
5.
6.
Nielsen W, Strand V, Simon L, Parodis I, Kim A, Desai M, et al.
Semin Arthritis Rheum
. 2024 Jan;
65:152380.
PMID: 38281467
Background: The Outcome Measures in Rheumatology (OMERACT) Systemic Lupus Erythematosus (SLE) Working Group held a Special Interest Group (SIG) at the OMERACT 2023 conference in Colorado Springs where SLE collaborators...
7.
Lee I, Gomez A, Kim A, Coble D, Marshall B, Shah A, et al.
J Clin Rheumatol
. 2023 Oct;
30(2):e58-e62.
PMID: 37798827
Objective: To determine the association between disease activity and choroidal thickness in patients with systemic lupus erythematosus (SLE). Methods: We conducted a cohort study of 24 SLE patients and 13...
8.
Coler-Reilly A, Graef E, Kim A, Liew J, Putman M, Sattui S, et al.
Rheumatol Immunol Res
. 2023 Aug;
4(2):107-108.
PMID: 37637225
No abstract available.
9.
Neupane B, Shukla P, Slim M, Martin A, Petri M, Bertsias G, et al.
Lupus Sci Med
. 2023 May;
10(1).
PMID: 37147022
Objective: To generate comparative efficacy evidence of belimumab versus anifrolumab in SLE that can inform treatment practices. Methods: The SLE Responder Index (SRI)-4 response at 52 weeks of belimumab versus...
10.
Coler-Reilly A, Graef E, Kim A, Liew J, Putman M, Sattui S, et al.
Rheumatol Immunol Res
. 2023 Mar;
3(4):169-179.
PMID: 36879836
Social media has become an important venue for rheumatologists, patients, organizations, and other stakeholders to discuss recent research advances in diagnosis and management of rheumatic disorders. In this article, we...